LENZ Historical Financial Ratios
| LENZ Stock | 26.95 1.16 4.50% |
LENZ Therapeutics is lately reporting on over 72 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 16.95 will help investors to properly organize and evaluate LENZ Therapeutics financial condition quickly.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LENZ Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. About LENZ Financial Ratios Analysis
LENZ TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate LENZ Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on LENZ financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across LENZ Therapeutics history.
LENZ Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing LENZ Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on LENZ Therapeutics sales, a figure that is much harder to manipulate than other LENZ Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from LENZ Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into LENZ Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LENZ Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy LENZ Stock please use our How to Invest in LENZ Therapeutics guide.At this time, LENZ Therapeutics' PTB Ratio is fairly stable compared to the past year. PB Ratio is likely to rise to 0.52 in 2025, whereas Book Value Per Share is likely to drop 16.95 in 2025.
| 2024 | 2025 (projected) | Interest Debt Per Share | 0.04 | 0.038 | Revenue Per Share | 1.72 | 1.53 |
LENZ Therapeutics fundamentals Correlations
Click cells to compare fundamentals
LENZ Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
LENZ Therapeutics fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | (74.13) | 1.25 | 0.42 | 0.55 | 0.5 | 0.52 | |
| Book Value Per Share | (1.18) | 47.04 | 37.8 | 22.54 | 20.29 | 16.95 | |
| Free Cash Flow Yield | (0.0141) | (0.12) | (0.77) | (1.0) | (1.15) | (1.09) | |
| Operating Cash Flow Per Share | (1.05) | (6.38) | (11.22) | (11.05) | (12.71) | (13.34) | |
| Pb Ratio | (74.13) | 1.25 | 0.42 | 0.55 | 0.5 | 0.52 | |
| Free Cash Flow Per Share | (1.24) | (7.07) | (12.06) | (12.38) | (14.24) | (14.95) | |
| Net Income Per Share | (8.24) | (8.54) | (12.89) | (15.3) | (17.6) | (18.48) | |
| Cash Per Share | 2.39 | 45.49 | 34.22 | 22.82 | 20.54 | 16.78 | |
| Pocfratio | (83.3) | (9.22) | (1.4) | (1.12) | (1.01) | (1.06) | |
| Pfcf Ratio | (70.77) | (8.32) | (1.3) | (1.0) | (0.9) | (0.95) | |
| Income Quality | 0.13 | 0.75 | 0.87 | 0.72 | 1.19 | 1.25 | |
| Ev To Operating Cash Flow | (81.03) | (2.09) | (0.92) | (0.74) | 0.32 | 0.33 | |
| Pe Ratio | (10.63) | (6.89) | (1.22) | (0.81) | (0.73) | (0.77) | |
| Ev To Free Cash Flow | (68.84) | (1.89) | (0.86) | (0.66) | 0.31 | 0.33 | |
| Net Debt To E B I T D A | 0.29 | 5.38 | 0.43 | 0.28 | 0.26 | 0.27 | |
| Current Ratio | 0.66 | 31.44 | 21.11 | 39.2 | 20.36 | 15.04 | |
| Tangible Book Value Per Share | (1.18) | 47.04 | 37.8 | 22.54 | 20.29 | 16.95 | |
| Shareholders Equity Per Share | (1.18) | 47.04 | 37.8 | 22.54 | 20.29 | 16.95 | |
| Graham Net Net | (1.51) | 44.02 | 30.95 | 22.22 | 20.0 | 15.26 | |
| Enterprise Value Over E B I T D A | (10.36) | (1.58) | (0.83) | (0.54) | (0.49) | (0.51) | |
| Roe | 6.98 | (0.18) | (0.34) | (0.68) | (0.78) | (0.74) | |
| Return On Tangible Assets | (3.03) | (0.18) | (0.31) | (0.66) | (0.6) | (0.63) | |
| Earnings Yield | (0.0941) | (0.15) | (0.82) | (1.23) | (1.42) | (1.35) | |
| Price Earnings Ratio | (10.63) | (6.89) | (1.22) | (0.81) | (0.73) | (0.77) | |
| Price Book Value Ratio | (74.13) | 1.25 | 0.42 | 0.55 | 0.5 | 0.52 | |
| Price To Operating Cash Flows Ratio | (83.3) | (9.22) | (1.4) | (1.12) | (1.01) | (1.06) | |
| Price To Free Cash Flows Ratio | (70.77) | (8.32) | (1.3) | (1.0) | (0.9) | (0.95) | |
| Ebt Per Ebit | 5.06 | 1.17 | 0.96 | 1.7 | 1.96 | 2.78 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LENZ Stock Analysis
When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.